GT
DXCM icon

Glenview Trust’s DexCom DXCM Stock Holding History

Glenview Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,556
Closed -$216K – 469
2024
Q1 		$216K Buy
+1,556
New +$196K ﹤0.01% 451
2023
Q3 		– Sell
-2,087
Closed -$268K – 450
2023
Q2 		$268K Sell
2,087
-3
-0.1% -$363 0.01% 401
2023
Q1 		$243K Buy
2,090
+16
+0.8% +$1.79K 0.01% 406
2022
Q4 		$235K Buy
+2,074
New +$228K 0.01% 402

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glenview Trust's DXCM Position: Q2 2024 in Review

Glenview Trust sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,556 shares — an estimated $216K sold.

Glenview Trust first reported a position in DXCM in Q4 2022 and held it in 4 quarters. The position peaked at $268K in Q2 2023. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Glenview Trust reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Glenview Trust sold 1,556 DexCom shares in Q2 2024, an estimated $216K.
  • Glenview Trust first reported a position in DexCom in Q4 2022 and held it in 4 quarters.
  • Glenview Trust's DexCom position peaked at $268K in Q2 2023.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Glenview Trust's 13F filing for Q2 2024, filed 14 Aug 2024.